Die Grafik zeigt die prognostizierten Quartalsgewinne (Bereinigter Gewinn pro Aktie, EPS) und die tatsächlich erzielten Gewinne (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Umsatz (USD)
Schätzung
Umsatz
Die Grafik zeigt die prognostizierten Quartalsumsätze und die tatsächlich erzielten Umsätze (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Güte der Analystenschätzungen – EPS (aktueller Zeitraum)
Quartal / Datum
EPS (USD)
Schätzung (USD)
Abweichung
Quartal / Datum
Umsatz (Mio USD)
Schätzung (Mio USD)
Abweichung
Revisionen der Gewinnschätzungen
EPS-Schätzungen für die Geschäftsjahre
2027, 2028, 2029.
The headline numbers for Valvoline (VVV) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Valvoline NYSE: VVV reported higher fiscal fourth-quarter sales and earnings before interest, taxes, depreciation and amortization, but rising lubricant costs weighed on margins as the oil-change chain forecast further pressure in fiscal 2027.
Valvoline (VVV) came out with quarterly earnings of $0.42 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.45 per share a year ago.
LEXINGTON, Ky.--(BUSINESS WIRE)--Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today reported financial results for its fourth quarter ended September 30, 2026. All comparisons in this press release are made to the same prior-year period unless otherwise noted. "As we close fiscal 2026, we are pleased with our performance and proud to celebrate our 20th consecutive year of system-wide same-store sales growth," said Lori Flees, President and CE.
Valvoline Inc. remains a Buy as fundamentals strengthen despite a 22.4% share price decline versus the S&P 500. VVV delivered 24.1% revenue growth, and 8% same-store sales gains and expanded its location footprint, with profitability metrics broadly improving. Management raised FY2026 guidance: revenue to $2.05–$2.10B, adjusted EPS to $1.70–$1.75, and EBITDA to $550–$560M.
During this quarter, the Global Concentrated Small Cap strategy underperformed the MSCI World Small Cap Index. Encompass Health's shares rose after the company's results exceeded expectations, with discharge volumes growing faster than anticipated, and management raised its full-year revenue, profit and earnings guidance for the second consecutive quarter. Despite recent results exceeding expectations and MYR Group posting record revenue and backlog, shares fell over the course of the quarter on fears of growing political opposition to data center construction across the U.S.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Valvoline (VVV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
Portfolios
0
Zum Anlegen oder Bearbeiten von Portfolios müssen Sie sich anmelden oder einen Account erstellen.
Aktuelle Aktie in ein Portfolio speichern oder neues Portfolio anlegen: